Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 542

1.

How to evaluate effects of occupational therapy - lessons learned from an exploratory randomized controlled trial.

Schaeffer E, Streich S, Wurster I, Schubert R, Reilmann R, Wolfram S, Berg D.

Parkinsonism Relat Disord. 2019 Sep 19;67:42-47. doi: 10.1016/j.parkreldis.2019.09.013. [Epub ahead of print]

PMID:
31621606
2.

United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015.

Butler SS, Loeb S, Cole AP, Zaslowe-Dude C, Muralidhar V, Kim DW, Schaeffer EM, Trinh QD, Nguyen PL, Mahal BA.

Prostate Cancer Prostatic Dis. 2019 Oct 7. doi: 10.1038/s41391-019-0175-9. [Epub ahead of print]

PMID:
31591454
3.

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.

Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M, Elfandy H, Syamala S, Karoly ED, Alshalalfa M, Erho N, Ross A, Schaeffer EM, Gibb EA, Takhar M, Den RB, Lehrer J, Karnes RJ, Freedland SJ, Davicioni E, Spratt DE, Ellis L, Jaffe JD, DʼAmico AV, Kantoff PW, Bradner JE, Mucci LA, Chavarro JE, Loda M, Brown M.

Nat Commun. 2019 Sep 25;10(1):4358. doi: 10.1038/s41467-019-12298-z.

4.

Definitive and sustained increase in prostate cancer metastases in the United States.

Patel NA, Sedrakyan A, Bianco F, Etzioni R, Gorin MA, Hsu WC, Mao J, Nguyen PL, Schaeffer E, Shoag J, Vickers A, Hu JC.

Urol Oncol. 2019 Sep 12. pii: S1078-1439(19)30320-5. doi: 10.1016/j.urolonc.2019.08.002. [Epub ahead of print]

PMID:
31522862
5.

Re: A Population-Based Cohort Study of the Impact of Infectious Complications Requiring Hospitalization after Prostate Biopsy on Radical Prostatectomy Surgical Outcomes.

Schaeffer EM.

J Urol. 2019 Sep 13:101097JU0000000000000551. doi: 10.1097/JU.0000000000000551. [Epub ahead of print] No abstract available.

PMID:
31518190
6.

Re: Incidence and Microbiology of Post-Operative Infections after Radical Cystectomy and Ureteral Stent Removal; A Retrospective Cohort Study.

Schaeffer EM.

J Urol. 2019 Sep 13:10109701JU00005852206810294. doi: 10.1097/01.JU.0000585220.68102.94. [Epub ahead of print] No abstract available.

PMID:
31518186
7.

Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.

Spratt DE, Alshalalfa M, Fishbane N, Weiner AB, Mehra R, Mahal BA, Lehrer J, Liu Y, Zhao SG, Speers C, Morgan TM, Dicker AP, Freedland SJ, Karnes RJ, Weinmann S, Davicioni E, Ross AE, Den RB, Nguyen PL, Feng FY, Lotan TL, Chinnaiyan AM, Schaeffer EM.

Clin Cancer Res. 2019 Sep 12. doi: 10.1158/1078-0432.CCR-19-1587. [Epub ahead of print]

PMID:
31515456
8.

Ultrasound Characteristics of Clinically Dislocated But Reducible Hips With DDH.

Striano B, Schaeffer EK, Matheney TH, Upasani VV, Price CT, Mulpuri K, Sankar WN; International Hip Dysplasia Institute.

J Pediatr Orthop. 2019 Oct;39(9):453-457. doi: 10.1097/BPO.0000000000001048.

PMID:
31503230
9.

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.

Van den Broeck T, Moris L, Gevaert T, Tosco L, Smeets E, Fishbane N, Liu Y, Helsen C, Margrave J, Buerki C, Davicioni E, Van Poppel H, Everaerts W, Weinmann S, Den R, Davis J, Schaeffer E, Karnes RJ, Claessens F, Joniau S.

Eur Urol Oncol. 2019 Sep;2(5):589-596. doi: 10.1016/j.euo.2018.12.007. Epub 2019 Jan 11.

PMID:
31411980
10.

Re: Reduced Recurrence of Low-Grade Papillary Bladder Tumors Associated with Asymptomatic Bacteriuria.

Schaeffer EM.

J Urol. 2019 Aug 6:101097JU0000000000000485. doi: 10.1097/JU.0000000000000485. [Epub ahead of print] No abstract available.

PMID:
31385735
11.

Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.

Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM.

Urol Oncol. 2019 Aug;37(8):563. doi: 10.1016/j.urolonc.2019.07.003. No abstract available.

PMID:
31351589
12.

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease.

Schaeffer E, Busch JH, Roeben B, Otterbein S, Saraykin P, Leks E, Liepelt-Scarfone I, Synofzik M, Elshehabi M, Maetzler W, Hansen C, Andris S, Berg D.

Front Neurol. 2019 Jun 19;10:646. doi: 10.3389/fneur.2019.00646. eCollection 2019.

13.

Re: Ibuprofen versus Pivmecillinam for Uncomplicated Urinary Tract Infection in Women-A Double-Blind, Randomized Non-Inferiority Trial.

Schaeffer EM.

J Urol. 2019 Jul 4:101097JU0000000000000432. doi: 10.1097/JU.0000000000000432. [Epub ahead of print] No abstract available.

PMID:
31271546
14.

Re: Once-Daily Plazomicin for Complicated Urinary Tract Infections.

Schaeffer EM.

J Urol. 2019 Jul 4:10109701JU0000576820062388b. doi: 10.1097/01.JU.0000576820.06238.8b. [Epub ahead of print] No abstract available.

PMID:
31271545
15.

DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.

Kothari V, Goodwin JF, Zhao SG, Drake JM, Yin Y, Chang SL, Evans JR, Wilder-Romans K, Gabbara K, Dylgjeri E, Chou J, Sun G, Tomlins SA, Mehra R, Hege K, Filvaroff EH, Schaeffer EM, Karnes RJ, Quigley DA, Rathkopf DE, He HH, Speers C, Spratt DE, Gilbert LA, Ashworth A, Chinnaiyan AM, Raj GV, Knudsen KE, Feng FY.

Clin Cancer Res. 2019 Sep 15;25(18):5608-5622. doi: 10.1158/1078-0432.CCR-18-2387. Epub 2019 Jul 2.

PMID:
31266829
16.

Re: Association of Screening and Treatment for Preoperative Asymptomatic Bacteriuria with Postoperative Outcomes among US Veterans.

Schaeffer EM.

J Urol. 2019 Sep;202(3):441. doi: 10.1097/JU.0000000000000370. Epub 2019 Aug 8. No abstract available.

PMID:
31169452
17.

Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.

Alshalalfa M, Nguyen PL, Beltran H, Chen WS, Davicioni E, Zhao SG, Rebbeck TR, Schaeffer EM, Lotan TL, Feng FY, Mahal BA.

Eur Urol Oncol. 2019 Jul;2(4):405-412. doi: 10.1016/j.euo.2019.05.001. Epub 2019 Jun 2.

PMID:
31164324
18.

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.

Alshalalfa M, Liu Y, Wyatt AW, Gibb EA, Tsai HK, Erho N, Lehrer J, Takhar M, Ramnarine VR, Collins CC, Den RB, Schaeffer EM, Davicioni E, Lotan TL, Bismar TA.

Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32430. [Epub ahead of print]

PMID:
31125117
19.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

20.

African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.

Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Den RB, Cleveland JL, Park JY, Rayford W, Yamoah K.

J Urol. 2019 Aug;202(2):247-255. doi: 10.1097/JU.0000000000000193. Epub 2019 Jul 8.

PMID:
31107158
21.

Prostate cancer in sexual minorities and the influence of HIV status.

Amarasekera C, Wong V, Yura E, Manjunath A, Schaeffer E, Kundu S.

Nat Rev Urol. 2019 Jul;16(7):404-421. doi: 10.1038/s41585-019-0194-2. Review.

PMID:
31101896
22.

Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?

Rao A, Vapiwala N, Schaeffer EM, Ryan CJ.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:309-320. doi: 10.1200/EDBK_239041. Epub 2019 May 17.

PMID:
31099652
23.

Germline and Somatic Mutations in Prostate Cancer for the Clinician.

Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.

J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307. Review.

PMID:
31085765
24.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
25.

Re: Continuous Low-Dose Antibiotic Prophylaxis for Adults with Repeated Urinary Tract Infections (AnTIC): A Randomised, Open-Label Trial.

Schaeffer EM.

J Urol. 2019 Aug;202(2):191. doi: 10.1097/JU.0000000000000302. Epub 2019 Jul 8. No abstract available.

PMID:
31021292
26.

The Utility of Prostate Specific Antigen Density, Prostate Health Index, and Prostate Health Index Density in Predicting Positive Prostate Biopsy Outcome is Dependent on the Prostate Biopsy Methods.

Lopes Vendrami C, McCarthy RJ, Chatterjee A, Casalino D, Schaeffer EM, Catalona WJ, Miller FH.

Urology. 2019 Jul;129:153-159. doi: 10.1016/j.urology.2019.03.018. Epub 2019 Mar 27.

PMID:
30926382
27.

Re: Effect of a Hospital-Associated Urinary Tract Infection Reduction Policy on General Surgery Patients.

Schaeffer EM.

J Urol. 2019 Jul;202(1):11-12. doi: 10.1097/JU.0000000000000254. Epub 2019 Jun 7. No abstract available.

PMID:
30925084
28.

sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide-mediated human dendritic cell activation in vitro and of acute inflammation in mice in vivo.

Schaeffer E, Sánchez-Fernández EM, Gonçalves-Pereira R, Flacher V, Lamon D, Duval M, Fauny JD, García Fernández JM, Mueller CG, Ortiz Mellet C.

Eur J Med Chem. 2019 May 1;169:111-120. doi: 10.1016/j.ejmech.2019.02.078. Epub 2019 Mar 5.

PMID:
30870792
29.
30.

Re: The Use of Intravesical Gentamicin to Treat Recurrent Urinary Tract Infections in Lower Urinary Tract Dysfunction.

Schaeffer EM.

J Urol. 2019 Jun;201(6):1035-1036. doi: 10.1097/01.JU.0000554667.00259.a6. No abstract available.

PMID:
30865853
31.

TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer.

Kaur HB, Lu J, Guedes LB, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tomlins SA, Sfanos KS, Eisenberger M, Schaeffer EM, Joshu CE, Lotan TL.

Hum Pathol. 2019 May;87:95-102. doi: 10.1016/j.humpath.2019.02.006. Epub 2019 Mar 6.

PMID:
30851334
32.

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.

Faisal FA, Kaur HB, Tosoian JJ, Tomlins SA, Schaeffer EM, Lotan TL.

Prostate Cancer Prostatic Dis. 2019 Mar 8. doi: 10.1038/s41391-019-0139-0. [Epub ahead of print]

PMID:
30850708
33.
34.

Re: First Experience in the UK of Treating Women with Recurrent Urinary Tract Infections with the Bacterial Vaccine Uromune®.

Schaeffer EM.

J Urol. 2018 Dec;200(6):1144-1145. doi: 10.1016/j.juro.2018.09.025. No abstract available.

PMID:
30838901
35.

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.

Liu D, Takhar M, Alshalalfa M, Erho N, Shoag J, Jenkins RB, Karnes RJ, Ross AE, Schaeffer EM, Rubin MA, Trock B, Klein EA, Den RB, Tomlins SA, Spratt DE, Davicioni E, Sboner A, Barbieri CE.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00036. Epub 2018 Jul 24.

36.

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16.

37.

Re: Preoperative Urine Culture is Unnecessary in Asymptomatic Men prior to Prostate Needle Biopsy.

Schaeffer EM.

J Urol. 2019 Mar;201(3):422-423. doi: 10.1097/01.JU.0000553661.93137.6c. No abstract available.

PMID:
30759635
38.

Re: Comparison of Fosfomycin against Fluoroquinolones for Transrectal Prostate Biopsy Prophylaxis: An Individual Patient-Data Meta-Analysis.

Schaeffer EM.

J Urol. 2019 May;201(5):839-840. doi: 10.1097/JU.0000000000000164. No abstract available.

PMID:
30747893
39.

Re: Correlation of Inflammatory Mediators in Prostatic Secretion with Chronic Prostatitis and Chronic Pelvic Pain Syndrome.

Schaeffer EM.

J Urol. 2019 May;201(5):840. doi: 10.1097/01.JU.0000554003.38258.e0. No abstract available.

PMID:
30747892
40.

Closed Reduction for Developmental Dysplasia of the Hip: Early-term Results From a Prospective, Multicenter Cohort.

Sankar WN, Gornitzky AL, Clarke NMP, Herrera-Soto JA, Kelley SP, Matheney T, Mulpuri K, Schaeffer EK, Upasani VV, Williams N, Price CT; International Hip Dysplasia Institute.

J Pediatr Orthop. 2019 Mar;39(3):111-118. doi: 10.1097/BPO.0000000000000895.

41.

Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.

Strauch MA, Tomaz MA, Monteiro-Machado M, Cons BL, Patrão-Neto FC, Teixeira-Cruz JDM, Tavares-Henriques MDS, Nogueira-Souza PD, Gomes SLS, Costa PRR, Schaeffer E, da Silva AJM, Melo PA.

PLoS One. 2019 Jan 28;14(1):e0211229. doi: 10.1371/journal.pone.0211229. eCollection 2019.

42.

Re: Antimicrobial Resistance in Women with Urinary Tract Infection in Primary Care: No Relation with Type 2 Diabetes Mellitus.

Schaeffer EM.

J Urol. 2019 Apr;201(4):646. doi: 10.1097/JU.0000000000000100. No abstract available.

PMID:
30653000
43.

Re: Urinary Tract Infections following Radical Cystectomy and Urinary Diversion: A Review of 1133 Patients.

Schaeffer EM.

J Urol. 2019 Apr;201(4):647. doi: 10.1097/01.JU.0000553309.83315.fd. No abstract available.

PMID:
30652999
44.

Re: Does Size Matter? Measured and Modeled Effects of Suprapubic Catheter Size on Urinary Flow.

Schaeffer EM.

J Urol. 2019 Feb;201(2):209. doi: 10.1097/01.JU.0000553053.43925.fe. No abstract available.

PMID:
30634305
45.

Need for Higher Quality Evidence to Determine the Utility of Postoperative Radiography.

Teo TL, Schaeffer EK, Mulpuri K.

J Am Acad Orthop Surg Glob Res Rev. 2018 Aug 2;2(8):e026. doi: 10.5435/JAAOSGlobal-D-18-00026. eCollection 2018 Aug. No abstract available.

46.

National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.

Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM.

Urol Oncol. 2019 Jun;37(6):353.e1-353.e8. doi: 10.1016/j.urolonc.2018.12.022. Epub 2019 Jan 2. Erratum in: Urol Oncol. 2019 Aug;37(8):563.

PMID:
30611643
47.

Re: Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

Schaeffer EM.

J Urol. 2019 Jan;201(1):11. doi: 10.1097/01.ju.0000550113.95081.b9. No abstract available.

PMID:
30577340
48.

Re: Bacteria on Urine Microscopy is Not Associated with Systemic Infection in Patients with Obstructing Urolithiasis.

Schaeffer EM.

J Urol. 2019 Jan;201(1):10-11. doi: 10.1097/01.ju.0000550112.95081.f0. No abstract available.

PMID:
30577339
49.

Inflammatory Bowel Disease and the Risk of Prostate Cancer.

Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, Strong S, Burns J, Hussain MHA, Kundu SD.

Eur Urol. 2019 May;75(5):846-852. doi: 10.1016/j.eururo.2018.11.039. Epub 2018 Dec 4.

PMID:
30528221
50.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi D, Tosoian JJ, Nyame YA, Alam R, Achim M, Reichard CA, Li J, Wilkins L, Schwen Z, Han M, Davis JW, Klein EA, Schaeffer EM, Stephenson AJ, Ross AE, Chapin BF.

Cancer. 2019 Feb 1;125(3):391-397. doi: 10.1002/cncr.31833. Epub 2018 Nov 13.

PMID:
30423193

Supplemental Content

Loading ...
Support Center